News

Filter

Current filters:

HerceptinAsia-Pacific

Mylan debuts Hertraz, first Herceptin biosimilar, in India

Mylan debuts Hertraz, first Herceptin biosimilar, in India

03-02-2014

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product,…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazIndiaMarkets & MarketingMylan LaboratoriesOncologyRoche

Celltrion’s trastuzumab biosimilar, Herzuma, approved in South Korea

16-01-2014

South Korean biopharmaceutical firm Celltrion has received approval for its cancer treatment biosimilar…

Asia-PacificBiosimilarsCellTrionGenericsHerceptinHerzumaOncologyRegulationRoche

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

Clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015

05-02-2012

Based on clinical data and the opinions of interviewed thought leaders, Roche/Genentech/Chugai’s…

Asia-PacificEuropeHerceptinMarkets & MarketingNorth AmericaOncologyPharmaceuticalRocheTaxotere

Roche/Chugai get recurrent gastric cancer indication for Herceptin in Japan

11-03-2011

Chugai Pharmaceutical , a Japanese subsidiary of Swiss drug major Roche (SIX: ROG), has obtained approval…

Asia-PacificChugai PharmaceuticalHerceptinOncologyPharmaceuticalRegulationRoche

Switzerland’s Roche eyes up China’s potential

02-03-2010

China’s economy is rocketing, with Gross Domestic Product expanding at a double-digit annual rate,…

Asia-PacificcapecitabineerlotinibFinancialHerceptinMarkets & MarketingPharmaceuticalRituxanrituximabRocheTarcevatrastuzumabXeloda

COMPANY SPOTLIGHT

Menarini

Back to top